The purpose of this annual event is to look at the challenges facing therapeutic protein production and demystify some of the novel approaches and new technologies currently being developed
Wednesday, 15 May 2013
The Stevenage Bioscience Catalyst , UK
This event is part of the 2013 Euroscicon BioTherapeutics Week,
to find out more see www.biotherapeutics2013.com
Speakers include:
Dr Tim Overton, University of Birmingham, UK
Mr Andrew Clutterbuck, Merck Millipore
Professor Bazbek Davletov, Chair of Biomedical Sciences, University of Sheffield, UK
Dr Graziella El Khoury, University of Cambridge, UK
Professor Richard J Ross, University of Sheffield
Event Web site: www.regonline.co.uk/protein2013
Tags: AAV vectors, Analysis, antibody, antibody purification, biopharmaceutical manufacturing processes, botulinum, Cell line development, Cell line engineering, cell line selection, CHO, CHO cell lines, domain, E.coli, endogenous genome, Fusion, Gene correction/modification, gene targeting, genetic algorithms, glycosylation, Growth Hormone, homologous recombination, Long Acting Biological, mammalian expression systems, microbial, multi-product facility design, Nanoscale, NTA, process economics, protein, Protein Aggregation, protein linking, protein therapeutics, screening., stapling, therapeutic
Follow Us!